91 related articles for article (PubMed ID: 3282577)
1. [Value of immunological analysis for the detection of residual neuroblasts in the bone marrow].
Combaret V; Favrot MC; Bailly C; Philip I; Zucker JM; Philip T
Bull Cancer; 1988; 75(1):79-82. PubMed ID: 3282577
[TBL] [Abstract][Full Text] [Related]
2. [The significance of immunological analysis for the detection of residual neuroblasts in bone marrow].
Maritaz O; Combaret V; Favrot MC
Pathol Biol (Paris); 1988 Jan; 36(1):21-4. PubMed ID: 3283668
[TBL] [Abstract][Full Text] [Related]
3. [Cytologic detection of neuroblasts in the bone marrow].
Bayle C
Bull Cancer; 1988; 75(1):75-7. PubMed ID: 3282576
[TBL] [Abstract][Full Text] [Related]
4. [Detection of residual cells contaminating the bone marrow in neuroblastoma. Apropos of 80 bone marrow evaluations].
Frappaz D; Maritaz O; Favrot MC; Philip I; Bernard JL; Bailly C; Gentilhomme O; Gentet JC; Zucker JM; Bouffet E
Arch Fr Pediatr; 1987 Nov; 44(9):771-8. PubMed ID: 3446068
[TBL] [Abstract][Full Text] [Related]
5. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
6. Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction.
Tsang KS; Li CK; Tsoi WC; Leung Y; Shing MM; Chik KW; Lee V; Ng MH; Yuen P
Cancer; 2003 Jun; 97(11):2887-97. PubMed ID: 12767104
[TBL] [Abstract][Full Text] [Related]
7. Detection of isolated tumor cells in neuroblastoma by immunohistochemical analysis in bone marrow biopsy specimens: improved detection with use of beta-catenin.
Krishnan C; Twist CJ; Fu T; Arber DA
Am J Clin Pathol; 2009 Jan; 131(1):49-57. PubMed ID: 19095565
[TBL] [Abstract][Full Text] [Related]
8. Metastatic neoplasms of bone marrow. Clinical and morphological analysis of 71 cases.
Zheng TL; Li DG; Zhang ZN; Cao JN; Li GX
Chin Med J (Engl); 1985 May; 98(5):321-4. PubMed ID: 3926402
[No Abstract] [Full Text] [Related]
9. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.
Swerts K; De Moerloose B; Dhooge C; Brichard B; Benoit Y; Laureys G; Philippé J
Cytometry B Clin Cytom; 2004 Sep; 61(1):9-19. PubMed ID: 15351977
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer.
Ross AA; Miller GW; Moss TJ; Kahn DG; Warner NE; Sweet DL; Louie KG; Schneidermann E; Pecora AL; Meagher RC
Bone Marrow Transplant; 1995 Jun; 15(6):929-33. PubMed ID: 7581093
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow.
Okcu MF; Wang RY; Bueso-Ramos C; Schober W; Weidner D; Andrassy R; Blakely M; Russell H; Ozkan A; Kuttesch J; Andreeff M; Chan KW; Ater J
Pediatr Blood Cancer; 2005 Nov; 45(6):787-95. PubMed ID: 15929127
[TBL] [Abstract][Full Text] [Related]
12. Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method.
Naume B; Borgen E; Tøssvik S; Pavlak N; Oates D; Nesland JM
Cytotherapy; 2004; 6(3):244-52. PubMed ID: 15203981
[TBL] [Abstract][Full Text] [Related]
13. [The identification of minimal residual disease in the bone marrow and peripheral blood in neuroblastoma. The prognostic and therapeutic implications].
Faulkner LB; Tamburini A; Tintori V; Paoli A; Tondo A; Bernini G; Medicina D; Brisigotti M; Corrias MV; Scaruffi P; Rosanda C; Lo Piccolo MS; Viscardi E; Milanaccio C; Garaventa A; De Bernardi B
Pediatr Med Chir; 1998; 20(3):175-8. PubMed ID: 9744008
[TBL] [Abstract][Full Text] [Related]
14. Combined automatic immunological and molecular cytogenetic analysis allows exact identification and quantification of tumor cells in the bone marrow.
Méhes G; Luegmayr A; Ambros IM; Ladenstein R; Ambros PF
Clin Cancer Res; 2001 Jul; 7(7):1969-75. PubMed ID: 11448912
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of stage IV neuroblastoma with high-dose melphalan and autologous bone marrow transplantation following in vitro preliminary treatment of the bone marrow with the active cyclophosphamide derivative Asta Z-7654].
Urban C; Slace I; Kaulfersch W; Greinix H; Höcker P
Padiatr Padol; 1986; 21(3):275-82. PubMed ID: 3534689
[TBL] [Abstract][Full Text] [Related]
16. Vacuolated cells in bone marrow aspirate of children with neuroblastoma.
Yildirim ZK; Buyukavci M
Pediatr Hematol Oncol; 2008 Sep; 25(7):665-72. PubMed ID: 18850479
[TBL] [Abstract][Full Text] [Related]
17. Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system.
Kraeft SK; Sutherland R; Gravelin L; Hu GH; Ferland LH; Richardson P; Elias A; Chen LB
Clin Cancer Res; 2000 Feb; 6(2):434-42. PubMed ID: 10690521
[TBL] [Abstract][Full Text] [Related]
18. Sensitive detection of metastatic tumor cells in bone marrow.
Moss TJ
Prog Clin Biol Res; 1994; 389():567-77. PubMed ID: 7700922
[No Abstract] [Full Text] [Related]
19. Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvests.
Rinaldi C; Savignano C; Silvestri F; Geromin A; Cerno M; Fanin R; Biffoni F; Baccarani M
Haematologica; 1995; 80(5):443-7. PubMed ID: 8566888
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow enrichment technique for detection and characterization of scarce abnormal cells.
Fillola GM; Laharrague PF; Corberand JX
Nouv Rev Fr Hematol (1978); 1992; 34(4):337-41. PubMed ID: 1448354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]